-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Hold on Sage Therapeutics, Raises Price Target to $9

Benzinga·06/17/2025 14:39:24
Listen to the news
Truist Securities analyst Joon Lee maintains Sage Therapeutics (NASDAQ:SAGE) with a Hold and raises the price target from $8 to $9.